Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies Post author: Post published:March 18, 2024 Post category:uncategorized Immunome signs deal to use Arrayjet platform in its in-house screening operations. You Might Also Like Diabetes-Friendly Starbucks Drinks December 27, 2023 GluFormer outperforms existing AI models in predicting blood sugar levels August 26, 2024 Gender differences explored: Cardiovascular health variances in women’s lifespan February 27, 2024